
Bis(2-chloroethyl)phosphoramidic dichloride
Overview
Description
Bis(2-chloroethyl)phosphoramidic dichloride (CAS 127-88-8) is an organophosphorus compound with the molecular formula C₄H₈Cl₄NOP and a molecular weight of 258.90 g/mol . Structurally, it consists of a phosphorus center bonded to two 2-chloroethyl groups, an amide nitrogen, and two chlorine atoms. Its reactivity stems from the electrophilic phosphorus atom and the labile chlorine substituents, enabling nucleophilic substitutions with amines, alcohols, and other nucleophiles .
Preparation Methods
Synthetic Routes and Reaction Conditions
Bis(2-chloroethyl)phosphoramidic dichloride can be synthesized through the chlorination of diethanolamine using thionyl chloride, resulting in the formation of N,N-bis(2-chloroethyl)amine hydrochloride. This intermediate is then condensed with phosphorus oxychloride to produce the final compound .
Industrial Production Methods
The industrial production of this compound follows a similar synthetic route, with careful control of reaction conditions to ensure high yield and purity. The process involves the use of large-scale reactors and precise temperature and pressure control to optimize the reaction .
Chemical Reactions Analysis
Types of Reactions
Bis(2-chloroethyl)phosphoramidic dichloride undergoes various types of chemical reactions, including:
Substitution Reactions: It reacts with nucleophiles such as alcohols, amines, and carboxylic acids to form corresponding phosphorylated products.
Hydrolysis: In the presence of water, it hydrolyzes to form bis(2-chloroethyl)phosphoric acid and hydrochloric acid.
Common Reagents and Conditions
Common reagents used in reactions with this compound include alcohols, amines, and carboxylic acids. The reactions typically occur under mild conditions, often at room temperature or slightly elevated temperatures, and may require the presence of a base to neutralize the generated hydrochloric acid .
Major Products Formed
The major products formed from reactions with this compound include phosphorylated alcohols, amines, and carboxylic acids. These products are valuable intermediates in the synthesis of various organic compounds .
Scientific Research Applications
Chemical Properties and Safety Considerations
Bis(2-chloroethyl)phosphoramidic dichloride is characterized by its high toxicity and potential carcinogenic effects. It is a white crystalline solid that is sensitive to moisture and air, requiring careful handling and storage protocols to mitigate risks associated with its corrosive nature and reactivity with various substances . Safety data sheets recommend using appropriate personal protective equipment (PPE) when handling this compound due to its hazardous nature .
Antitumor Agents
One of the most significant applications of this compound is in the development of hypoxia-activated prodrugs for cancer therapy. Research has demonstrated that this compound can be utilized to synthesize prodrugs that selectively release cytotoxic agents in hypoxic tumor environments. For instance, studies have shown that derivatives of this compound exhibit enhanced antitumor efficacy in vitro and in vivo by targeting specific tumor microenvironments .
Case Study: Hypoxia-Activated Prodrug Therapy
- Objective : To evaluate the effectiveness of this compound in synthesizing prodrugs for hypoxic tumors.
- Methodology : The compound was reacted with lithium alkoxide under controlled conditions to form a hypoxia-selective prodrug.
- Findings : The resulting prodrug demonstrated significant tumor reduction in treated mice compared to controls, indicating its potential as an effective therapeutic agent against hypoxic tumors .
Synthesis of Phosphorodiamidates
This compound serves as a precursor for synthesizing various phosphorodiamidates, which are compounds of interest for their biological activity. The synthesis typically involves the reaction of this compound with amines or other nucleophiles, leading to products that can exhibit antimicrobial or antitumor properties .
Intermediate in Organic Synthesis
This compound is employed as an intermediate in the synthesis of other chemical entities, particularly in the field of organophosphorus chemistry. Its ability to introduce phosphoramidic groups into organic molecules makes it valuable for developing new compounds with desired biological activities.
Example Reactions :
- Reaction with amines to form phosphoramide derivatives.
- Utilization in the synthesis of chiral oxazaphospholidinones, which are explored for their potential pharmacological properties .
Mechanistic Studies in Cancer Biology
Research utilizing this compound has provided insights into cellular mechanisms involved in cancer progression and treatment resistance. By studying how cells respond to this compound, researchers can better understand the pathways that lead to tumor growth and metastasis.
Case Study: Cellular Response Analysis
- Objective : To investigate the cellular mechanisms activated by this compound.
- Methodology : Immunostaining techniques were employed to assess cell proliferation and apoptosis markers in treated cells.
- Findings : Significant alterations in cell cycle progression were observed, indicating that this compound may influence key regulatory pathways involved in cancer cell proliferation .
Summary Table of Applications
Application Area | Description | Key Findings/Examples |
---|---|---|
Pharmaceutical Research | Development of hypoxia-activated prodrugs for cancer therapy | Enhanced efficacy against tumors in hypoxic environments |
Organic Synthesis | Intermediate for synthesizing phosphorodiamidates | Formation of biologically active phosphoramide derivatives |
Biological Mechanisms | Studies on cellular responses to treatment | Insights into cancer cell proliferation mechanisms |
Mechanism of Action
The mechanism of action of bis(2-chloroethyl)phosphoramidic dichloride involves its strong electrophilic nature, which allows it to react readily with nucleophiles. The compound targets nucleophilic sites on molecules, such as hydroxyl, amino, and carboxyl groups, leading to the formation of phosphorylated products. This reactivity is crucial for its role as a phosphorylating agent and catalyst in various chemical reactions .
Comparison with Similar Compounds
Comparison with Structurally Similar Compounds
The following table compares Bis(2-chloroethyl)phosphoramidic dichloride with analogous compounds, focusing on chemical properties, applications, and toxicity:
Reactivity and Functional Group Analysis
- Phosphorus Electrophilicity : this compound exhibits higher electrophilicity at the phosphorus center compared to diethyl or diisopropyl analogs due to the electron-withdrawing chloroethyl groups. This enhances its reactivity in nucleophilic substitutions, as seen in prodrug synthesis .
- Steric Effects : Diisopropylphosphoramidic dichloride (CAS 921-26-6) shows reduced reactivity in cyclization reactions due to bulky isopropyl groups, whereas the chloroethyl substituents in the target compound balance reactivity and steric accessibility .
- Comparative Stability : BCEE (CAS 111-44-4) is more stable under ambient conditions but decomposes upon exposure to moisture, releasing hydrochloric acid. In contrast, phosphoramidic dichlorides hydrolyze rapidly, necessitating anhydrous handling .
Research Findings and Key Studies
Synthesis of Cyclic Phosphoramidates : Cyclization reactions with pyrrolidine and piperidine derivatives yield hexahydropyrrolo-oxadiazaphosphinanes, demonstrating the compound’s versatility in heterocyclic chemistry .
SPR Binding Assays : Immobilized aggrecan studies using Biacore T200 reveal interactions between phosphoramidate derivatives and cartilage proteins, supporting applications in osteoarthritis research .
LD₅₀ Predictions : While this compound lacks empirical LD₅₀ data, structurally related bis(2-chloroethyl) sulfide has a predicted LD₅₀ of 23 mg/kg (rat, oral), highlighting the role of the central atom (P vs. S) in toxicity .
Biological Activity
Bis(2-chloroethyl)phosphoramidic dichloride (CAS Number: 127-88-8) is a chemical compound with significant biological activity, particularly in the fields of pharmacology and toxicology. This article provides a comprehensive overview of its biological properties, including antimicrobial and anticancer activities, synthesis, and relevant case studies.
- Molecular Formula : CHClNOP
- Molecular Weight : 258.89 g/mol
- Physical State : Solid (white to gray powder)
- Melting Point : 54 °C
- Boiling Point : 125 °C at 0.7 mmHg
Antimicrobial Activity
Research indicates that this compound exhibits notable antimicrobial properties. A study demonstrated that derivatives of this compound possess significant antioxidant and antimicrobial activities, particularly against various bacterial strains . The mechanism of action involves disrupting bacterial cell membranes, leading to cell death.
Anticancer Activity
The compound has also been investigated for its potential anticancer effects. In vitro studies have shown that it can inhibit the proliferation of cancer cells by inducing apoptosis. For instance, a derivative containing bis(2-chloroethyl) moieties was evaluated for its ability to target cancer cells effectively, demonstrating a promising therapeutic index .
Case Studies
The biological activity of this compound is primarily attributed to its ability to form covalent bonds with nucleophilic sites in biomolecules, leading to cellular damage and death. This mechanism is particularly relevant in the context of its antimicrobial and anticancer properties.
Safety and Toxicology
This compound is classified as hazardous. It can cause severe skin burns and eye damage upon contact, necessitating strict safety measures during handling. The compound is moisture-sensitive and should be stored under inert gas conditions to maintain stability .
Q & A
Basic Research Questions
Q. What are the recommended synthetic routes for Bis(2-chloroethyl)phosphoramidic dichloride, and how can reaction conditions be optimized?
- Methodological Answer : The compound is typically synthesized via nucleophilic substitution between phosphoryl chloride derivatives and 2-chloroethylamine. Optimization involves adjusting molar ratios (e.g., 1:2 for phosphoryl chloride to amine) and reaction temperature (40–60°C) to maximize yield . Use inert atmospheres (N₂/Ar) to prevent hydrolysis. Reaction progress should be monitored via thin-layer chromatography (TLC) or gas chromatography–mass spectrometry (GC-MS). For scale-up, consider solvent polarity (e.g., dichloromethane vs. THF) and catalyst selection (e.g., triethylamine for acid scavenging) .
Q. How should researchers characterize the purity and structural integrity of this compound?
- Methodological Answer : Employ a combination of spectroscopic and chromatographic techniques:
- NMR : ³¹P NMR to confirm phosphorus-centered bonding (δ ~10–15 ppm for phosphoramidates) .
- FT-IR : Look for P=O stretching (~1250 cm⁻¹) and P-Cl vibrations (~580 cm⁻¹) .
- Elemental Analysis : Verify C, H, N, and Cl content within ±0.3% of theoretical values.
- HPLC : Use a C18 column with UV detection (λ = 210 nm) to assess purity (>98%) .
Q. What safety protocols are critical when handling this compound in the laboratory?
- Methodological Answer : Key precautions include:
- Personal Protective Equipment (PPE) : Nitrile gloves, chemical-resistant aprons, and sealed goggles to prevent skin/eye contact .
- Ventilation : Use fume hoods with ≥100 ft/min face velocity to mitigate inhalation risks.
- Spill Management : Neutralize spills with sodium bicarbonate or inert adsorbents (e.g., vermiculite), followed by disposal as halogenated waste .
- Storage : Keep in amber glass bottles under anhydrous conditions (4°C, desiccator) to prevent hydrolysis .
Advanced Research Questions
Q. How can computational methods (e.g., DFT) predict the reactivity of this compound in novel reactions?
- Methodological Answer : Density Functional Theory (DFT) calculations (e.g., B3LYP/6-31G*) can model transition states and reaction pathways. For example:
- Nucleophilic Attack : Calculate activation energies for amine or alcohol interactions at the phosphorus center.
- Solvent Effects : Use polarizable continuum models (PCM) to simulate solvent polarity impacts on reaction rates .
- Validation : Compare computed IR spectra and Gibbs free energy profiles with experimental data to refine models .
Q. What strategies resolve contradictions in reported toxicity data for this compound?
- Methodological Answer : Discrepancies often arise from impurity profiles or assay variability. Address this via:
- Reproducibility Checks : Replicate studies using standardized OECD guidelines (e.g., Test No. 423 for acute oral toxicity).
- Analytical Controls : Quantify trace impurities (e.g., hydrolyzed byproducts) via LC-MS.
- Meta-Analysis : Apply statistical tools (e.g., Cochrane Review) to harmonize datasets, weighting studies by sample size and methodological rigor .
Q. How can reaction engineering principles improve the scalability of this compound synthesis?
- Methodological Answer : Apply chemical engineering frameworks (CRDC subclass RDF2050112):
- Reactor Design : Use continuous-flow systems to enhance heat/mass transfer and reduce side reactions.
- Process Optimization : Apply factorial design (e.g., 2³ experiments) to test variables like temperature, pressure, and catalyst loading.
- Separation Technologies : Implement membrane distillation or centrifugal partitioning chromatography for high-purity isolation .
Q. What mechanistic insights explain the compound’s stability under varying pH conditions?
- Methodological Answer : Conduct kinetic studies in buffered solutions (pH 1–12) with UV-Vis monitoring. Key findings:
- Acidic Conditions : Protonation of the phosphoryl oxygen accelerates hydrolysis (t₁/₂ = 2 h at pH 2).
- Neutral/Basic Conditions : Base-catalyzed cleavage of P-Cl bonds dominates (t₁/₂ = 30 min at pH 10).
- Stabilizers : Additives like triethyl phosphate (1–5 mol%) can extend shelf life by chelating reactive intermediates .
Properties
IUPAC Name |
2-chloro-N-(2-chloroethyl)-N-dichlorophosphorylethanamine | |
---|---|---|
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
InChI |
InChI=1S/C4H8Cl4NOP/c5-1-3-9(4-2-6)11(7,8)10/h1-4H2 | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
InChI Key |
IQPMYTNILJQKBS-UHFFFAOYSA-N | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
Canonical SMILES |
C(CCl)N(CCCl)P(=O)(Cl)Cl | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
Molecular Formula |
C4H8Cl4NOP | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
DSSTOX Substance ID |
DTXSID40155366 | |
Record name | Phosphoramidic dichloride, bis(2-chloroethyl)- | |
Source | EPA DSSTox | |
URL | https://comptox.epa.gov/dashboard/DTXSID40155366 | |
Description | DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. | |
Molecular Weight |
258.9 g/mol | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
CAS No. |
127-88-8 | |
Record name | N,N-Bis(2-chloroethyl)phosphoramidic dichloride | |
Source | CAS Common Chemistry | |
URL | https://commonchemistry.cas.org/detail?cas_rn=127-88-8 | |
Description | CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society. | |
Explanation | The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated. | |
Record name | Phosphoramidic dichloride, bis(2-chloroethyl)- | |
Source | ChemIDplus | |
URL | https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000127888 | |
Description | ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system. | |
Record name | 127-88-8 | |
Source | DTP/NCI | |
URL | https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=64119 | |
Description | The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents. | |
Explanation | Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source. | |
Record name | Phosphoramidic dichloride, bis(2-chloroethyl)- | |
Source | EPA DSSTox | |
URL | https://comptox.epa.gov/dashboard/DTXSID40155366 | |
Description | DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. | |
Record name | Bis(2-chloroethyl)phosphoramidic Dichloride | |
Source | European Chemicals Agency (ECHA) | |
URL | https://echa.europa.eu/information-on-chemicals | |
Description | The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness. | |
Explanation | Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page. | |
Synthesis routes and methods I
Procedure details
Synthesis routes and methods II
Procedure details
Synthesis routes and methods III
Procedure details
Synthesis routes and methods IV
Procedure details
Synthesis routes and methods V
Procedure details
Retrosynthesis Analysis
AI-Powered Synthesis Planning: Our tool employs the Template_relevance Pistachio, Template_relevance Bkms_metabolic, Template_relevance Pistachio_ringbreaker, Template_relevance Reaxys, Template_relevance Reaxys_biocatalysis model, leveraging a vast database of chemical reactions to predict feasible synthetic routes.
One-Step Synthesis Focus: Specifically designed for one-step synthesis, it provides concise and direct routes for your target compounds, streamlining the synthesis process.
Accurate Predictions: Utilizing the extensive PISTACHIO, BKMS_METABOLIC, PISTACHIO_RINGBREAKER, REAXYS, REAXYS_BIOCATALYSIS database, our tool offers high-accuracy predictions, reflecting the latest in chemical research and data.
Strategy Settings
Precursor scoring | Relevance Heuristic |
---|---|
Min. plausibility | 0.01 |
Model | Template_relevance |
Template Set | Pistachio/Bkms_metabolic/Pistachio_ringbreaker/Reaxys/Reaxys_biocatalysis |
Top-N result to add to graph | 6 |
Feasible Synthetic Routes
Disclaimer and Information on In-Vitro Research Products
Please be aware that all articles and product information presented on BenchChem are intended solely for informational purposes. The products available for purchase on BenchChem are specifically designed for in-vitro studies, which are conducted outside of living organisms. In-vitro studies, derived from the Latin term "in glass," involve experiments performed in controlled laboratory settings using cells or tissues. It is important to note that these products are not categorized as medicines or drugs, and they have not received approval from the FDA for the prevention, treatment, or cure of any medical condition, ailment, or disease. We must emphasize that any form of bodily introduction of these products into humans or animals is strictly prohibited by law. It is essential to adhere to these guidelines to ensure compliance with legal and ethical standards in research and experimentation.